After taking his drug pricing argument to the public in the form of a newspaper op-ed, Sen. Bernie Sanders, I–Vt., is moving in Congress to …
Full story here.
Published by www.fiercepharma.com
Visited 1 times, 1 visit(s) today
September 7, 2022• byQuorum Call
After taking his drug pricing argument to the public in the form of a newspaper op-ed, Sen. Bernie Sanders, I–Vt., is moving in Congress to …